Huvitz

065510 · KOSDAQ · ₩065510 · 휴비츠

₩6,490 ₩0 (0.00%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −24.80%
Market cap
₩71B
Enterprise value
₩144B
P/E
49.3×
P/B
0.7×
Dividend yield
3.9%
ROE
1.3%
Net margin
1.2%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−35.7% from the high

₩6,270Today: ₩6,420 – ₩6,510₩10,090

Returns

  • 1W−3.6%
  • 1M−3.4%
  • 3M+1.2%
  • 6M−18.9%
  • YTD−29.1%
  • 1Y−24.8%
Volume today
15,998
0.6× the 20-day average
Traded today
₩103M
Listed shares
10,877,895
EPS (12 months)
₩132
Earnings yield 2.0%

Signals

36Quiet
  • BuzzQuietBuzz 36 of 100 (50 is a normal day for this stock).
  • MomentumFlat-1.8% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Huvitz stock overview

Huvitz (휴비츠, KRX: 065510) is listed on KOSDAQ, in the Medical & precision devices sector. The company develops and sells ophthalmic (eye care) medical devices, mainly optometry equipment used in eyeglass shops such as automatic refractors, lensmeters, chart projectors, and lens processing machines, as well as diagnostic and surgical devices used in eye hospitals. Its shares closed at ₩6,490 on Oct 28, 2026, unchanged on the day, giving it a market value of ₩71B.

Key facts

Market cap
₩71B
Sector
Medical & precision devices
Latest price change
0.00%
As of
Oct 28, 2026
Main business
The company develops and sells ophthalmic (eye care) medical devices, mainly optometry equipment used in eyeglass shops such as automatic refractors, lensmeters, chart projectors, and lens processing machines, as well as diagnostic and surgical devices used in eye hospitals.

Quick answers about Huvitz

What does Huvitz do?
The company develops and sells ophthalmic (eye care) medical devices, mainly optometry equipment used in eyeglass shops such as automatic refractors, lensmeters, chart projectors, and lens processing machines, as well as diagnostic and surgical devices used in eye hospitals. , European, and Japanese manufacturers, and notes that the business faces competition in pricing, distribution, and technology.
What is the market cap of Huvitz?
The market capitalisation of Huvitz was ₩71B at the close on Oct 28, 2026.
Who are the largest shareholders of Huvitz?
According to the latest official filings, the largest reported holders are Kim Hyun-soo (29.52%, as of Mar 5, 2026); EMERGING MARKETS CORE EQUITY 2 PORTFOLIO (0.36%, as of Jul 31, 2026); National Pension Service (0.16%, as of Dec 31, 2024).
When is the next earnings report from Huvitz?
Korean companies rarely announce results dates in advance. Based on when Huvitz filed the same report in past years, its next preliminary results is expected between Apr 28, 2026 and Oct 30, 2026.
Does the National Pension Service own Huvitz?
Yes. The National Pension Service held 0.16% of Huvitz shares as of Dec 31, 2024.

Company profile

The company develops and sells ophthalmic (eye care) medical devices, mainly optometry equipment used in eyeglass shops such as automatic refractors, lensmeters, chart projectors, and lens processing machines, as well as diagnostic and surgical devices used in eye hospitals. The report describes the global market for these products, which is led by U.S., European, and Japanese manufacturers, and notes that the business faces competition in pricing, distribution, and technology.

Written by AI from the company's latest annual report.

Korean name
휴비츠
CEO
김현수
Founded
Apr 1999
Listed
Oct 2003
Listed shares
10,877,895
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Huvitz / 휴비츠 / 065510 / KRX:065510

Source: KRX statistical information